Nanobiotix SA (EUR)
NANO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range7.71 | 8.00
52-Wk Range5.95 | 15.80
Last Close7.72
Mkt Cap (m)172.94
Dividend yield-
ISINFR0011341205
Volume56,767
Exchange VenuePAR

Company Profile

Nanobiotix SA is engaged in the development of NanoXray, a pipeline of patented products, which are based on a physical mechanism of action. It develops tools for cancer, which utilize a physical mode of action at the cellular level of the cancer cell.

Key Information
Price/Earning-
Price/Book8.34
Price/Sales46.56
P/CF-
Rev Growth (3 year avg)-3.87
EPS Growth (3 year avg)-
Operating Margin % -270.70
Net Margin %-895.40
Return on Equity-104.34
Debt/Equity1.44

Legal Documents

Annual Report
en 31/12/2015

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)224543
Operating Income (m)-8-10-17-22-25-9
Net Income (m)-8-10-17-22-26-30
Basic EPS-0.76-0.74-1.20-1.43-1.50-1.55
Avg. Diluted Shares Outstanding (m)111314151720
Balance Sheet
EUR201320142015201620172018
Current Assets (m)73623275343
Non Current Assets (m)123444
Total Assets (m)73726305746
Current Liabilities (m)3478912
Total Liabilities (m)------
Total Equity (m)33016174414
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)-7-9-17-18-21-26
Capital Expenditure (m)------1
Figures are quoted in EUR unless stated otherwise
0.00 (0.00%)
7.72
Last Price